STOCK TITAN

UTI (UTI) CEO Jerome Alan Grant sells 94,500 shares for tax planning

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

UNIVERSAL TECHNICAL INSTITUTE INC Chief Executive Officer Jerome Alan Grant sold 94,500 shares of common stock in open-market transactions. The sales occurred on June 29, 2026 at weighted average prices of $41.6294 and $41.1535 per share, according to the Form 4.

The filing notes that these sales were made for personal tax planning purposes. The transactions were reported as direct holdings of common stock, and no option exercises or derivative transactions were disclosed in this document.

Positive

  • None.

Negative

  • None.

Insights

CEO executes open-market stock sale tied to tax planning.

The Form 4 shows CEO Jerome Alan Grant completed open-market sales totaling 94,500 shares of UNIVERSAL TECHNICAL INSTITUTE INC common stock on June 29, 2026 at weighted average prices around $41 per share.

The footnotes state the sales were for personal tax planning purposes, which generally indicates a liquidity or tax-management decision rather than a change in company outlook. No option exercises or derivative positions are reported here, so this filing reflects straightforward share dispositions.

Because the document does not present the company’s total shares outstanding, the scale of these sales relative to the overall equity base cannot be assessed from this filing alone. As such, the informational value is primarily that the CEO reduced his direct common stock position by 94,500 shares in routine market transactions.

Insider Grant Jerome Alan
Role Chief Executive Officer
Sold 94,500 shs ($3.91M)
Type Security Shares Price Value
Sale Common Stock, $0.0001 par value 45,539 $41.1535 $1.87M
Sale Common Stock, $0.0001 par value 48,961 $41.6294 $2.04M
Holdings After Transaction: Common Stock, $0.0001 par value — 384,676 shares (Direct, null)
Footnotes (1)
  1. These shares were sold by the reporting person for personal tax planning purposes. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $40.50 to $41.495. The reporting person undertakes to provide the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $41.50 to $42.12. The reporting person undertakes to provide the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
Shares sold total 94,500 shares Open-market common stock sales on June 29, 2026
First transaction size 48,961 shares Common stock sale, open market
First transaction price $41.6294 per share Weighted average sale price
Second transaction size 45,539 shares Common stock sale, open market
Second transaction price $41.1535 per share Weighted average sale price
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
personal tax planning purposes financial
"These shares were sold by the reporting person for personal tax planning purposes."
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Grant Jerome Alan

(Last)(First)(Middle)
4225 E. WINDROSE DRIVE, SUITE 200

(Street)
PHOENIX ARIZONA 85032

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
UNIVERSAL TECHNICAL INSTITUTE INC [ UTI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/29/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock, $0.0001 par value06/29/2026S45,539(1)D$41.1535(2)384,676D
Common Stock, $0.0001 par value06/29/2026S48,961(1)D$41.6294(3)335,715D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. These shares were sold by the reporting person for personal tax planning purposes.
2. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $40.50 to $41.495. The reporting person undertakes to provide the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
3. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $41.50 to $42.12. The reporting person undertakes to provide the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
/s/ Christopher Kevane, Attorney-in-Fact for Jerome Alan Grant06/30/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did UTI’s CEO report on this Form 4?

UTI’s CEO, Jerome Alan Grant, reported selling 94,500 shares of common stock in open-market transactions. The trades took place on June 29, 2026, at weighted average prices slightly above $41 per share, according to the Form 4 filing.

At what prices did the UTI CEO sell his shares on June 29, 2026?

The CEO’s reported sales occurred at weighted average prices of $41.6294 and $41.1535 per share. Footnotes explain that each weighted average reflects multiple trades within price ranges roughly between $40.50 and $42.12 per share on that date.

How many UTI shares did Jerome Alan Grant sell in total?

The Form 4 shows that Jerome Alan Grant sold a total of 94,500 shares of Universal Technical Institute common stock. This total comes from two reported open-market sale transactions of 48,961 shares and 45,539 shares executed on June 29, 2026.

Why did UTI’s CEO say he sold these shares?

A footnote states that the shares were sold by the reporting person for personal tax planning purposes. This indicates the transactions were driven by individual tax considerations rather than any disclosed change in the company’s operations or strategy.

Were the UTI CEO’s June 29, 2026 trades single executions or multiple trades?

The reported prices are weighted averages, and the footnotes clarify that each sale covered multiple transactions. Those individual trades occurred within specified price ranges between about $40.50 and $42.12 per share on June 29, 2026.

Does this UTI Form 4 include any option exercises or derivative transactions?

No, the insider data indicate only non-derivative common stock sales. The derivativeSummary section is empty, and the transaction codes are both “S,” which correspond to open-market or private sale transactions of existing common shares.